Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies

DS Reddy - Experimental neurology, 2023 - Elsevier
Novel and effective antiseizure medications are needed to treat refractory and rare forms of
epilepsy. Cannabinoids, which are obtained from the cannabis plant, have a long history of …

The many faces of calcineurin inhibitor toxicity—What the FK?

SS Farouk, JL Rein - Advances in Chronic Kidney Disease, 2020 - Elsevier
Calcineurin inhibitors (CNIs) are both the savior and Achilles' heel of kidney transplantation.
Although CNIs have significantly reduced rates of acute rejection, their numerous toxicities …

Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial

EA Thiele, EM Bebin, H Bhathal, FE Jansen… - JAMA …, 2021 - jamanetwork.com
Importance Efficacy of cannabidiol has been demonstrated in seizures associated with
Lennox-Gastaut and Dravet syndromes but appears not yet to have been established in …

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process

A Bhaskar, A Bell, M Boivin, W Briques… - Journal of cannabis …, 2021 - Springer
Background Globally, medical cannabis legalization has increased in recent years and
medical cannabis is commonly used to treat chronic pain. However, there are few …

Highly purified cannabidiol for epilepsy treatment: A systematic review of epileptic conditions beyond dravet syndrome and Lennox–Gastaut syndrome

S Lattanzi, E Trinka, P Striano, C Rocchi, S Salvemini… - CNS drugs, 2021 - Springer
Background Cannabidiol (CBD), which is one major constituent of the Cannabis sativa plant,
has anti-seizure properties and does not produce euphoric or intrusive side effects. A plant …

Emerging use of epidiolex (cannabidiol) in epilepsy

R Abu-Sawwa, B Scutt, Y Park - The Journal of Pediatric …, 2020 - meridian.allenpress.com
The first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication,
Epidiolex, was approved in the United States by the FDA on June 25, 2018. Its approval for …

[HTML][HTML] Cannabidiol interactions with medications, illicit substances, and alcohol: a comprehensive review

P Balachandran, M Elsohly, KP Hill - Journal of general internal medicine, 2021 - Springer
Cannabidiol, a non-intoxicating phytocannabinoid, has potential therapeutic effects over a
broad range of disorders. Recently, there has been increased interest in CBD, as several …

Cannabinoid interactions with cytochrome P450 drug metabolism: a full-spectrum characterization

PT Doohan, LD Oldfield, JC Arnold, LL Anderson - The AAPS journal, 2021 - Springer
Medicinal cannabis use has increased exponentially with widespread legalization around
the world. Cannabis-based products are being used for numerous health conditions, often in …

Cannabidiol therapy for refractory epilepsy and seizure disorders

V Golub, DS Reddy - Cannabinoids and neuropsychiatric disorders, 2021 - Springer
Cannabis-derived cannabinoids have neuroactive properties. Recently, there has been
emerging interest in the use of cannabidiol (CBD)-enriched products for treatment of drug …

Cytochrome P450–catalyzed metabolism of cannabidiol to the active metabolite 7-hydroxy-cannabidiol

JL Beers, D Fu, KD Jackson - Drug Metabolism and Disposition, 2021 - ASPET
Cannabidiol (CBD) is a naturally occurring nonpsychotoxic phytocannabinoid that has
gained increasing attention as a popular consumer product and for its use in Food and Drug …